Tianjin Ringpu Bio-Technology Co.,Ltd. Stock: price and insider trades · China
瑞普生物
No insider purchase over the last 90 days. The latest, by 徐雷, was filed 16 Jun 2026.
Tianjin Ringpu Bio-Technology Co.,Ltd.: what insiders have been doing
Every trade that managers of Tianjin Ringpu Bio-Technology Co.,Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. In the past year (6 November 2025 to 6 November 2026), 1 filing came from 1 insider.
Every open-market trade in the period is a purchase: 1 purchase worth €892k, from 1 insider, and not a single sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Biggest ticket of the year: €892k, bought by 徐雷 and made public on 16 June 2026. On the buying side, the filings list 1 chief executive among the declarants.
The latest purchase dates back some time: it was published 145 days ago, on 16 June 2026.
For context, the typical company on the same exchange (median of 522 companies) published 2 filings over the same period, against 1 filing here. Our records for Tianjin Ringpu Bio-Technology Co.,Ltd. go back to 2023, with 2 purchases and no sales on the open market in total.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- +12.5%Entry CN¥15.30 · Close 05 Nov 2026 CN¥17.22
- -15.4%Entry CN¥19.44 · Close at T+365 CN¥16.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Tianjin Ringpu Bio-Technology Co.,Ltd.
瑞普生物 is a company focused on the health and pharmaceutical sector, specializing in the research and development of biopharmaceutical solutions. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
